Molecular Neuromodulation
21 – 30 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?
(
- Contribution to journal › Scientific review
-
Mark
Deep learning-enhanced light-field imaging with continuous validation
(
- Contribution to journal › Article
- 2020
-
Mark
AAV Production Everywhere : A Simple, Fast, and Reliable Protocol for In-house AAV Vector Production Based on Chloroform Extraction
(
- Contribution to journal › Article
-
Mark
Deep learning-enhanced light-field imaging with continuous validation
2020) In bioRxiv(
- Working paper/Preprint › Preprint in preprint archive
- 2019
-
Mark
Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain
(
- Contribution to journal › Article
-
Mark
A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(52). p.27053-27062(
- Contribution to journal › Article
-
Mark
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
(
- Contribution to journal › Article
- 2018
-
Mark
Repairing the brain : Gene therapy
(
- Contribution to journal › Scientific review
-
Mark
A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency
(
- Contribution to journal › Article